EventInvest
Sign in
Genomic Valley Biotech LtdGVBL

Genomic Valley Biotech Ltd: Open offer

MR. PANKAJ GROVER has made an open offer for up to 26% of Genomic Valley Biotech Ltd at ₹30 a share.

Tendering opensin 28 dayssoonStage 3 of 7: Draft letter filed

Terms

Each figure links to its source
Offer price
₹30
Shares sought
7,94,170
Of voting capital
26%
Trigger
Took control
Tendering opens
14 Dec 2026
Tendering closes
28 Dec 2026
SEBI observations
Not known: Awaiting SEBI observations
Competing offer
No
Acquirer
MR. PANKAJ GROVER
  • Dates marked expected are the latest the SAST Regulations allow from the last stated date.

Timeline

8 steps
  1. Public announcement19 Oct 2026
  2. Detailed public statement27 Oct 2026
  3. Draft letter of offer filed with SEBIDate not yet stated

5 more steps, each with its date and filing. Free with a Google sign-in.

Sign in with Google

Source documents

3 filings

3 filings from the exchanges and SEBI, with links. Free with a Google sign-in.

Sign in with Google

What this means for a shareholder

When someone acquires 25% or more of a listed company, or control of it, the SAST Regulations require them to offer to acquire at least a further 26% from public shareholders at a price no lower than the regulation’s floor.

The offer runs through a public announcement, a detailed statement, a draft letter with SEBI, SEBI’s observations, a ten-day tendering window and payment. If more is tendered than sought, acceptance is proportionate.

How open offers work, step by step →

Updated 19:27 IST · Information from public filings. Not investment advice.